Versión de HTML Básico
10
Leticia Soriano Carrascosa
Uso de antihipertensivos en ancianos
REFERENCIAS
1. Bulpitt CJ, Beckett NS, Cooke J et al; Hypertension in the Very El-
derly Trial Working Group. Results of the pilot study for the Hypertension
in the Very Elderly Trial. J Hypertens. 2003; 21: 2409-2417.
2. Sierra C, López-Soto A, Coca A. La hipertensión en la población
anciana. Rev Esp Geriatr Gerontol. 2008; 43: 53-59
3. Beckett N, Peters R, Fletcher A et al. of the HYVET Study Group.
Treatment of Hypertension in patients 80 years old or older. N Engl J Med.
2008; 358: 1887-1898
4. Staessen JA, Fagard R, Thijs L et al of the Systolic Hypertension
in Europe (Syst-Eur) Trial Investigators. Randomised double blind com-
parison of placebo and active treatment for older patients with Isolated
Systolic Hypertension. Lancet 1997; 350: 757-764.
5. Lobos JM, Royo-Bordonada MA, Brotons C et al. Guía Europea de
Prevención Cardiovascular. Adaptación Española del CEIPC. Rev. Esp Salud
Publ. 2008. 82: 581-616.
6. Mansilla S, García ME, García E et al.Factores de riesgo vascular
en personas de edad avanzada. Prevalencia en una consulta externa de
geriatría de un hospital general. Rev Esp Geriatr Gerontol 2004; 39(Supl
2): 50-51.
7. Amery A, Birkenhager W, Brixco P et al. Mortality and morbidity
results from the European Working Party on High Blood Pressure in the
Elderly trial. Lancet 1985; 2: 1349-54.
8. Mancia G, De Backer G,Dominiczak A et al. 2007 Guidelines for
the Management of Arterial Hypertension. The Task Force for the Mana-
gement of Arterial Hypertension of the European Society of Cardiology
(ESC). J Hypertens 2007;25 1105-87
9. The ONTARGET Investigators. Telmisartan, Ramipril, or Both in
Patient at High Risk for Vascular Events. .N Engl J Med 2008;358: 1547-59.